559.77USD-1.30%Mkt Cap: —P/E: 65.781d ago
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It opera…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value44.60B $
Revenue (TTM)4.55B $
Gross Profit2.84B $
Net Income (TTM)1.14B $
Revenue/Share57.17 USD
Last Price559.77 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11.0K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINUS45168D1046
Valuation
P/E (Trailing)65.78
P/E (Forward)—
PEG—
EV/EBITDA27.50
EV/Revenue9.80
P/S—
P/B27.35
EPS (TTM)8.52
EPS (Forward)—
52W Range
543.0050% of range576.44
52W High576.44 USD
52W Low543.00 USD
Profitability
Gross Margin62.45%
Oper. Margin34.98%
EBITDA Margin35.62%
Profit Margin25.03%
ROE74.21%
ROA27.08%
Growth
Revenue Growth9.70%
Earnings Growth17.60%
Cash Flow & Leverage
Operating CF1.37B $
CapEx (TTM)—
FCF Margin19.97%
FCF Yield—
Net Debt899.15M $
Net Debt/EBITDA0.55
Balance Sheet
Debt/Equity67.97
Current Ratio1.17
Quick Ratio0.73
Book Value/Sh20.45 USD
Cash/Share2.500 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.86.23M
Float78.50M
Insiders0.22%
Institutions96.80%
Technical
SMA 50548.90 (+2.0%)
SMA 200498.86 (+12.2%)
Beta1.54
S&P 52W Chg20.80%
Avg Vol (30d)65
Avg Vol (10d)803
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—